Teglicar is a selective and reversible orally active liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor with an IC50 value of 0.68 μM and a Ki value of 0.36 μM. Teglicar has a potential antihyperglycemic propert. Teglicar can be used for the research of diabetes and neurodegenerative disease including Huntington's disease (HD).
PEGylation of Protein, Peptide & Oligo > Lipid Molecules > Cationic Lipid | Drug Delivery, Surface Modification > Lipid Molecules > Cationic Lipid | Products > Lipids In Drug Delivery > Cationic Lipid | Products > Lipids In Drug Delivery > Cationic Lipid > Carnitine
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。